Pfizer Stock Price

Central Index Key (CIK): 78003 | ISIN: US7170811035 | Symbol: PFE | Type: Stock.
Pfizer Inc. Is one of the largest players in the global pharmaceutical market, a manufacturer of medicines and vaccines. Among others, it supplies Lipitor (Atorvastatin), a popular drug for lowering cholesterol levels. In 2020, the corporation gained even more prominence by becoming one of the manufacturers of the COVID-19 vaccine. Interest in the company grew significantly throughout 2020. Pfizer's global prominence as one of the earliest suppliers of a coronavirus vaccine, along with rising financial performance, has affected Pfizer's stock price. Pfizer (NYSE:PFE) stock price online, charts, stock price history, technical and fundamental analysis, reports, dividends, comments and more.

Simple and lightweight Pfizer Stock Live Chart is a powerful free tool that allows you to easily conduct technical analysis online without downloading additional files and applications. In order to meet the needs of the most demanding technical analysts, you can find over a hundred chart analysis tools on our Pfizer stock chart. You can also add any of 80 technical indicators directly to the chart online - in two clicks. The possibilities are endless!

Technical Analysis Pfizer Stock

Pfizer Stocks Technical Analysis widget is a modern handy tool that shows ratings based on technical indicators data. The design of the widget is made in the form of a speedometer, thanks to which you can quickly see the results of the summary technical analysis. You no longer need to use many indicators for analyzing financial instruments, the widget will do it for you. In addition, all rating data are updated in real time. These technical indicators are used for technical analysis: Relative Strength Index, Stochastic, Commodity Channel Index, Average Directional Index, Awesome Oscillator, Momentum, MACD, Stochastic RSI, Williams Percent Range, Bull Bear Power, Ultimate Oscillator, Exponential Moving Average, Simple Moving Average, Ichimoku Cloud Base Line, Volume Weighted Moving Average, Hull Moving Average.

Fundamental Analysis Pfizer Stock

The widget displays fundamental data that will help you better understand the current state of the company than simple stock prices. Pfizer stock fundamentals include: Market Capitalization, Enterprise Value, Balance Sheet, Operating Metrics, Price History, Margins, Income Statement, Dividends and many others important data.

About Pfizer Inc.

Pfizer Inc. Is one of the largest players in the global pharmaceutical market, a manufacturer of medicines and vaccines. Among others, it supplies Lipitor (Atorvastatin), a popular drug for lowering cholesterol levels. In 2020, the corporation gained even more prominence by becoming one of the manufacturers of the COVID-19 vaccine. Interest in the company grew significantly throughout 2020. Pfizer's global prominence as one of the earliest suppliers of a coronavirus vaccine, along with rising financial performance, has affected Pfizer's stock price.

The company was founded in 1849 by Charles Faiser and Charles Ehrhardt in New York, USA. A small pharmaceutical business was started in Brooklyn with the production of a remedy for intestinal parasites (a common problem in the mid-19th century). The drug quickly gained popularity due to its pleasant taste.

The first name was Charles Pfizer & Co. The small brick building was both an office, a laboratory and a factory.

You can invest in stocks of the pharmaceutical giant Pfizer with the help of a broker. Investors choose different strategies in relation to Pfizer stock. It can be a long-term investment with the expectation of raising to the target price, receiving dividends or buying for a short time.

A Brief History of Pfizer Inc. Stocks

1891 - Charles Erhardt's heir William sold his share to a partner;

1936-1940 - Pfizer takes the lead in vitamin C production in the world and begins to develop other complex vitamins;

1942 - Publication of Pfizer shares on the stock market;

1943 - the company mass-produced the antibacterial drug Penicillin, which was critically needed during the Second World War. The success was ensured by the use of fermentation technology - Pfizer was the only company that managed to use it;

1950 - the first drug under the Pfizer brand was released in the USA, its own development - a broad-spectrum antibiotic "Oxytetracycline";

1961 - the corporation has a new office. He is still in New York, but not in Brooklyn, but in Manhattan;

1971 - the foundation is laid for the future research center of the world scale;

2000 - merged with Warner-Lambert. Thanks to this, the assortment was replenished with a wide range of drugs for the correction of pathologies of the cardiovascular system, mental disorders, the treatment of various infections;

2003 - merger with Pharmacia, which significantly strengthened the research area of ​​activity;

2009 - Pfizer acquires Wyeth, expanding its product portfolio even further;

2011 - the production of a vaccine against pneumococcal infection was launched.

In 2020, the corporation devoted a significant part of its resources to establishing the production of a vaccine against coronavirus. Production lines in the States and Europe were urgently redesigned for new needs. More than a billion doses are expected from Pfizer by the end of 2021.

Now Pfizer Inc. Is one of the leading pharmaceutical companies in the United States, its shares can be found on the NYSE under the ticker PFE.

The stock market is invariably responsive to news regarding the supply of the drug. Pfizer stock prices are influenced by reports of delays, new research, etc. It is important for an investor to assess the situation correctly in order to make profitable decisions.

If you are planning to buy Pfizer shares, it is important to consider various factors: company-specific news, general trends in the securities market, etc.

According to the results of 2020, Pfizer's capitalization amounted to $ 204 billion. Revenue - $ 41.9 billion, and net profit - $ 12.5 billion.

During the annual report (early days of February 2021), Pfizer's plans for a COVID-19 vaccine were announced. The company expects sales to be around $ 15 billion.

Pfizer Stock: An In-Depth Analysis for Investors

Introduction:
Investing in the stock market requires a thorough understanding of various companies and their potential for growth. One such company that has garnered significant attention from investors is Pfizer Inc., a leading biopharmaceutical company. This article aims to present a comprehensive analysis of Pfizer's stock, focusing on its financial performance, market position, recent developments, and potential investment opportunities.

Financial Performance:
Pfizer's financial performance has been robust, making it an attractive choice for investors seeking stability and growth. With a market capitalization exceeding $200 billion, the company has consistently delivered strong revenue and profit margins. Notably, Pfizer's revenue for 2020 was $41.9 billion, demonstrating its resilience amid the global economic downturn caused by the COVID-19 pandemic.

Market Position:
Pfizer holds a prominent position within the pharmaceutical industry, boasting a diverse portfolio of innovative medications and vaccines. The company operates across different therapeutic areas, including oncology, immunology, and rare diseases, which ensures a broad revenue base. Moreover, Pfizer's extensive global reach and established distribution networks provide a competitive advantage, contributing to its market dominance.

COVID-19 Vaccine Success:
One of Pfizer's recent achievements that has significantly impacted its stock position is the successful development and global distribution of the COVID-19 vaccine. Collaborating with BioNTech, Pfizer's vaccine has been authorized for emergency use worldwide. The successful rollout demonstrates Pfizer's capability to respond to critical healthcare needs, further enhancing its reputation and financial prospects.

R&D Pipeline:
Pfizer's commitment to research and development (R&D) indicates promising potential for future growth. The company invests substantial resources in discovering and developing innovative drug candidates. With several candidates currently in various stages of development, Pfizer's R&D pipeline is diversified and presents opportunities for both short-term and long-term market gains.

Competitive Landscape:
While Pfizer enjoys a strong market position, it faces competition from other pharmaceutical giants. Rivalry within the industry can impact Pfizer's market share and pricing power. Constant monitoring of competitors, their product pipelines, and regulatory approvals is essential for investors to assess the potential risks and rewards associated with owning Pfizer stock.

Regulatory Risks:
The biopharmaceutical industry is subject to stringent regulations and intellectual property challenges. Changes in regulatory frameworks and the expiration of patents can impact Pfizer's revenue streams. Investors should carefully evaluate the regulatory landscape to understand the potential risks and legal implications associated with Pfizer's operations.

Conclusion:
Pfizer's performance, market position, and recent developments make it an intriguing choice for investors seeking exposure to the pharmaceutical industry. Robust financials, the successful COVID-19 vaccine, a diversified R&D pipeline, and a strong global presence contribute to Pfizer's growth potential. However, investors should conduct thorough research, considering the competitive landscape and regulatory risks associated with the industry. With a disciplined approach, investors can make informed decisions about including Pfizer stock in their investment portfolios.

Have Questions?

If you have any questions, then use the comments - and we will answer 100%, the average response time is 24 hours. Please note that your comments are pre-checked by the site administrators - therefore, your comment on the site will be published over time.